Fighting Pneumonia With a Toothbrush: New Program Is Yielding Results

Bottom of the article
A woman smiling with a toothbrush in front of her mouth.

A first-of-its-kind CVS Health initiative to combat hospital-acquired pneumonia through better oral health is improving outcomes and receiving rave reviews from patients. To date, the Rush to Brush program has reached more than 8,000 Aetna members scheduled for one of 23 types of inpatient surgery with kits containing high-quality oral care products, education and a personalized ‘get well’ card.
The effort is designed to help reduce the incidence of hospital-acquired pneumonia, one of the most common and life-threatening infections hospitalized patients can contract.

“We want to shift the paradigm around oral health in hospitals. It’s actually more important to take care of your teeth and mouth when you go in for surgery, not less,” said Mary Lee Conicella, DMD, Chief Dental Officer for Aetna.

Dr. Conicella noted that oral care is critically important in the post-operative setting because the mouth is filled with bacteria. One study found colonization by disease-causing bacteria — especially those linked to pneumonia — in 90 percent of patients within 72 hours of being admitted to the hospital. Those bacteria don’t just stay in the mouth, however; they are often inadvertently inhaled into the lungs.https://www.aha.org/2018-03-29-what-your-hospital-doing-about-1-hospital-acquired-infectionhttps://msphere.asm.org/content/1/4/e00199-16https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414413https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-016-0150-3

Brushing one’s teeth greatly reduces the population of bacteria in the mouth, according to nurse-researcher Dian Baker, Ph.D., professor at California State University, Sacramento.  “When patients brush their teeth, they’re basically taking their bacterial count from hundreds of millions down to just a few, and this greatly reduces their risk of pneumonia.”

Dr. Baker’s research inspired the Rush to Brush program, which is paying dividends in terms of clinical results, member satisfaction and reduced health care costs. To date, there has been about a 30 percent decrease in the incidence of pneumonia among members who received the Rush to Brush kit.Data based on early observations of pneumonia claims within 90 days of procedure for ~1,200 patients Additionally, estimates are that the program will yield approximately $75M in annual avoidable medical costs across Aetna’s commercial and Medicare business.

A note from a patient who took part in the Rush to Brush program.
A note from a patient who took part in the Rush to Brush program.

And members love it: Seventy percent took the kit with them to the hospital, and 95 percent have expressed positive feelings about the program and about Aetna. Members who received the kit have been effusive, saying the initiative “shows that Aetna is caring and considerate” and that “the fact that Aetna took a vested interested in my recovery meant so much.” One member noted that the kit “took the guess work out. All items were needed, all items were used — very important and useful.”

In addition to collaborating with Dr. Baker, Aetna worked with Johnson & Johnson and Colgate-Palmolive to outfit the kits with Colgate Total toothpaste, a high-quality toothbrush, Listerine Zero mouthwash and tips on good oral health.

The program illustrates unique ability of CVS Health and Aetna to use clinical and member data insights to unlock members’ health care needs, according to Daniel Knecht, M.D., Vice President of Health Strategy and Innovation for CVS Health. “Using those insights, we are then able to bring together the resources our members need on their road to recovery,” he added.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
3

One Goal: Making You Healthier

Stay Informed: Insights

I would like to receive: *
An alert each time a new article on key health care topics is published.
Leaders in Care: An email brief on key health care topics and events
Display Date

New Aetna Enhanced Medical Bundles Provides Cash Benefits to Members Following Unexpected Health Events

Bottom of the article

Most employers know that medical plans are a benefit that they are expected to offer to their employees. That’s the easy part. The difficult aspect is that medical plans come in many shapes and sizes, don’t always cover everything and those with high deductibles can leave employees with financial stress.

“Employers and their benefits advisers often face pressure to develop packages that deliver attractive, cost-effective options to a workforce with diverse needs,” said Randy Finn, Senior Director, Voluntary Business, Aetna. “Bundling a medical plan with a supplemental plan is a helpful solution that can deliver both administrative and cost efficiencies to employers, including savings on premiums and fees, while also enriching the benefits package they can offer their employees.”

In 2019, Aetna introduced the Aetna Enhanced Medical Bundle℠, which combines an Aetna medical plan with one or more of its supplemental plans. The Aetna supplemental plans pay cash benefits directly to members, which they can use to help cover medical plan expenses, like their deductible, or even everyday costs like childcare, rent and groceries. They also help ensure members can financially weather unexpected health events.

An Aetna Enhanced Medical Bundle can include one, two or all of three of the supplemental plans, which are:

  • Aetna Accident Plan: Cash payments for common services related to an accident, like a broken ankle.

  • Aetna Critical Illness Plan: Cash payments for expenses faced during a serious illness like cancer, stroke or heart attack.

  • Aetna Hospital Indemnity Plan: Cash payments for out-of-pocket costs associated with a planned or unplanned covered inpatient stay.

On top of cash benefits, bundled plans provide additional benefits to members. They can manage their medical and supplemental benefits through a single website, and Aetna leverages the medical claim so employees don’t have to submit additional paperwork to get their supplemental claim paid.

Through one or more supplemental plans, members gain a cost-effective means to minimize out-of-pocket medical expenses and protect themselves from a potentially financially devastating medical event.

“Whether its related to a high-deductible health plan or another medical plan, the supplemental plans under the Aetna Enhanced Medical Bundle can give members confidence that they have a safety net in the event of a health care need and the ease of an all-in-one process to manage their benefits,” said Pat McGinn, National Vice President of Sales, Aetna.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off

How we make coverage decisions

Bottom of the article

Whenever we tell members that a requested treatment is not covered, they want to know – how could we deny a procedure that their doctor believes could improve their quality of life? Our answer is based on scientific data – or lack thereof – and our responsibility to put member safety first.

It is never easy to tell an individual or family that a treatment or procedure is not approved – it’s the hardest thing we have to do. However, our guiding principles will continue to be proven effectiveness and member safety, as determined by rigorous scientific studies.

Only if effectiveness and safety are equivalent will we consider the relative cost-effectiveness of various treatments. In certain cases, we require a particular therapy to be tried before covering comparable, but more expensive options.

A member’s benefit plan defines the services that are covered and excluded. Our professional clinical staff develops clinical policy bulletins to inform members and providers which treatments are considered experimental and investigational, as well as the criteria that determine whether a technology or service is medically necessary. We use these bulletins to guide medical coverage decisions. Clinical policy bulletins do not guarantee coverage, but rather define when a service or treatment will be approved if it is not specifically excluded by the member’s plan.

Aetna’s clinical policy bulletins help guide evidence-based medicine that improves quality, reduces waste and provides members with access to affordable care. We constantly evaluate new published and peer-reviewed studies or additional evidence when developing our clinical policies, and will continue to do so.

For more information, please visit the clinical bulletins page or read the FAQ.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0

Pay Flex CEO Shines Light on Opportunity for Payers, Providers to Collaborate on Revenue Cycle

Bottom of the article

When it comes to health care costs, many consumers feel left in the dark. In fact, the No. 1 reason people do not pay their health care bills is due to confusion over the often antiquated and clunky payment process.

At the HIMSS Annual Conference & Exhibition in Las Vegas this week, PayFlex CEO and President Erin Hatzikostas hosted a session, “Equipping Consumers To Be The Chief Financial Officer Of Their Own Health Care,” to discuss how providers and health plans can work together to engage consumers to better understand and manage their health care expenses. PayFlex is a part of the Aetna family.

With the rise of consumer directed health plans turning patients into larger financial stakeholders in their care, “Consumers are left woefully behind in getting the information they need,” said Hatzikostas.

Consumers cannot make informed choices about their elective health care if they do not know what it costs. Furthermore, even after patients receive care, they are often left in a thicket of mail from providers and their insurer, including Explanations of Benefits (EOBs) which may look like bills, bills from providers that look like EOBs, etc.

While this is confusing for the patient, it also negatively affects doctors who performed services with the promise of getting compensated quickly. Collections typically take 3-5 months to process and only 17 percent of bills are collected. This delay is not linked to an unwillingness or inability by the patient to pay – three-fourths of people are willing and/or able to pay for their health care costs – but a lack of understanding of the payment system and process. “The No. 1 reason is that people were confused,” said Hatzikostas.

As a complex issue, the health care payment crisis requires a complex solution. Convenience and consumerism are hard to balance and simple solutions will not work.

In 2014, PayFlex launched Money Square for Health to help equip consumers to be better financial stewards of their health care. After just three years, the service earned over 200,000 users, with many repeat users. Beta testing confirmed the huge opportunity in the ecosystem to engage consumers and, with the learnings from Money Square for Health, Aetna launched AetnaPay to further empower consumers to become the CFO of their health care finances.

There is still much work to be done in supporting consumers to own their health care finances, but progress is being made. As we continue to shine a light on the payment black box, it will be imperative for providers to collaborate with health plans on solutions and work together to share quality data and advance work flows.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

Helping Seniors Save Money Through SilverScript

Bottom of the article

SilverScript, our Medicare-approved Part D prescription drug plan provider serving more than 5 million members, focuses on providing seniors and people with disabilities with consistent, worry-free coverage.

For Alexis Spina, one of our Pittsburgh-based colleagues, that focus is integral to her work every day. A clinical pharmacist, Spina works the Medicare call queue, educating members daily on lower cost drug alternatives that have the same clinical benefits as their current medications, tailoring her responses to each member’s specific level of understanding.

Her conversations with members have been so impactful that some of them have been developed into talk tracks that other colleagues on her team now use for their own calls.

Spina says that with each phone interaction she tries to make the patient feel like they are speaking with someone who truly cares about their well-being.

For her hard work and leadership, Spina was awarded a 2018 CVS Health Paragon Award, which recognizes the best-of-the-best among CVS Health colleagues who deliver direct care to patients and customers. Now in their 28th year, the Paragon Awards honor colleagues who embody the core values of CVS Health.

Watch to learn more about Spina’s passion for helping patients save money and live a healthier life.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
1
Display Hero
Off

Addressing Rising Drug Prices

Addressing Rising Drug Prices
Bottom of the article

Rising drug prices hurt patients and lead to negative and costly outcomes throughout our health care system. For example, data show that 40 percent of patients do not pick up their prescriptions when out-of-pocket costs per prescription exceed $200.CVS Health Internal Analysis. Completed December 2015, Retail RxDw; Analysis Timeframe of 1/1/15 – 12/28/15 When patients don’t take their medications as prescribed, the cost to our health care system is approximately $290 billion.https://www.nehi.net/writable/publication_files/file/pa_issue_brief_final.pdf

At CVS Health, we recognize that one of the most important things we can do is to help people afford and take their medications. That’s why we’re working to improve transparency and pioneering solutions to help patients get the right medicine at the lowest possible cost.

Providing Information across Multiple Points of Care

Information about how much a drug costs is not always readily available. According to a poll sponsored by CVS Health, more than half (57 percent) of patients do not know how much a drug will cost them, and nearly as many (54 percent) believe it would be helpful to have information about the cost before they fill their prescriptions.

CVS Health is working to expand visibility into drug cost information across multiple points of care.

  • At the physician’s office: Our real-time benefits technology – used by 100,000 prescribers nationwide – enables visibility into what a patient will pay for a specific drug under their benefits plan and presents up to five lower-cost, clinically appropriate alternatives for consideration by the prescriber.
  • At the pharmacy counter: Our more than 30,000 retail pharmacists use the Rx Savings Finder tool to search for potential savings opportunities.
  • For CVS Caremark members: About 230,000 times per month, CVS Caremark members search the Check Drug Cost tool to find lower-cost, clinically appropriate alternatives to more expensive medications.

Helping Control Costs While Promoting Better Health

As a Pharmacy Benefit Manager (PBM), we use every tool at our disposal to bring down drug prices. For example, we encourage the use of lower-cost, clinically appropriate generic alternatives, which data show can lead to a 3-percent decrease in overall mortality.https://www.ncbi.nlm.nih.gov/pubmed/2522238. We offer evidence-based guidelines to help prescribers connect patients to the most cost-effective medicines, resulting in more than $2.9 billion in savings.CVS Health White Paper. Current and New Approaches to Making Drugs More Affordable. Published August 2018 We also provide point-of-sale rebates and zero-dollar copay drug list options to clients, helping to deliver savings directly to patients at the pharmacy counter.

Keeping Costs Down for Patients, Employers and Government Programs

Our PBM strategies rein in costs across the health care system and also increase access to affordable medications for patients. While brand manufacturers have increased prices on average 9.2 percent annually from 2008 to 2016,https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2018.05147 we have worked to stabilize drug costs for our clients and patients. In fact, CVS Health kept drug price growth to just 0.2 percent in 2017.

For more information on how CVS Health is working to expand access to more affordable and effective health care, check out our Cost of Care information center and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our bi-weekly health care newsletter.

Pill bottle with dollar sign
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
6
Display Hero
Off

CVS Health PBM Solutions Blunted the Impact of Drug Price Inflation, Helped Reduce Member Cost, and Improved Medication Adherence in 2018

Top of the article

Over the past three years, CVS Caremark delivered $141B in prescription drug savings along with $18.3B in savings in avoided medical costs due to improved adherence

WOONSOCKET, R.I., April 11, 2019 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that, in 2018, the company's pharmacy benefit management (PBM) solutions blunted the impact of drug price inflation achieving a negative -4.2 percent price growth for non-specialty drugs and a 1.7 percent price growth for specialty drugs. Furthermore, 44 percent of CVS Caremark's commercial PBM clients saw their net prescription drug prices decline from 2017 to 2018. In addition, in 2018, CVS Caremark's focus on drug affordability, simplifying prescription management and applying interventions to improve medication adherence have helped increase the percentage of optimally adherent members in key chronic diseases such as diabetes, high cholesterol, and depression, which can result in reductions of nearly $2,000 in the overall cost of care per member.

"Over the last three years, even as drug prices have increased by 25 percent, CVS Caremark has helped our clients save more than $141 billion by blunting drug price inflation, prioritizing the use of effective, lower-cost drugs and reducing the member's out-of-pocket spend," said Derica Rice, president, CVS Caremark, the PBM business of CVS Health. "Moreover, our focused adherence efforts have helped more members take their drugs as prescribed, which we estimate has saved our clients an additional $18.3 billion in avoided medical costs since 2016."

Impact of Formulary Management

Managed formularies enable CVS Caremark to take advantage of market competition on behalf of its PBM clients and promote the use of effective, lower cost drugs. In fact, in 2018, clients that adopted the managed formularies offered by the Company saw savings of nearly 14 percent per 30-day prescription, even as drug price inflation, while slightly moderated, grew four times faster than overall inflation.

Managing Overall Spend for Diabetes and Making Insulin More Affordable

Rising costs for the treatment of diabetes continue to challenge payors and patients, but strategic management of the antidiabetic category helped CVS Caremark control overall spend. In 2018, trend for antidiabetic drugs was negative -1.7 percent, despite increasing utilization and brand price inflation of 5.6 percent.

Formulary management strategies also played a key role in helping keep insulin costs affordable for payors and consumers. In 2017, CVS Caremark led the market in taking steps to blunt the impact of branded insulin price increases by making the less expensive long-acting insulin Basaglar, the preferred drug on the formulary. This formulary change resulted in member out-of-pocket costs declining by nine percent, improved A1C levels, and savings for payors.

Improving Medication Adherence and Reducing Consumers Out-of-Pocket Costs

Despite the growth of high deductible plan designs, CVS Caremark's programs and solutions helped reduce out-of-pocket costs for consumers for the sixth straight year. In fact, two out of every three CVS Caremark members who used their prescription benefit in 2018 spent less than $100 on their prescriptions and more than 85 percent spent less than $300. In addition, although medical costs have grown 14 percent since 2013, over that time period CVS Caremark members paid 8.4 percent less for a 30 day prescription.

Containing Ever Increasing Costs for Specialty Drugs

The utilization and share of gross cost for specialty drugs continues to grow -- reaching 45 percent of total pharmacy spend in 2018, as compared to 42 percent in 2017 -- despite comprising only one percent of prescription claims overall. In 2018, although manufacturer-driven price inflation for specialty drugs measured 7.6 percent, CVS Caremark was able to keep specialty drug price growth at just 1.7 percent for clients. This was achieved through a tightly managed approach including effective formulary strategies, indication- and outcomes-based contracting, and utilization management to guide safe and appropriate use for patients dealing with complex and often debilitating conditions.

Prescription drug trend is the measure of growth in prescription spending per member per month. Trend calculations take into account the effects of drug price, drug utilization, and the mix of branded versus generic drugs as well as the positive effect of negotiated discounts and rebates on overall trend. The 2018 trend performance is based on a cohort of CVS Health commercial PBM clients employers and health plans.

To learn more about the CVS Caremark 2018 drug trend.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 92 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings. This innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0

SilverScript Insurance Company, a CVS Health Company, Introduces New Medicare Prescription Drug Plan Options for 2018

Top of the article

Plans feature $0-deductible for covered drugs in all tiers, low annual premiums, and $0 copays for some drugs when using CVS Caremark Mail Service Pharmacy

2018 plans maintain CMS 4-star quality and performance rating

WOONSOCKET, R.I., Oct. 12, 2017 /PRNewswire/ -- SilverScript Insurance Company, a CVS Health (NYSE: CVS) company, today announced its new Medicare Prescription Drug Plan (PDP) options for 2018. Medicare beneficiaries in the continental U.S. can choose from two SilverScript plans that offer a $0-deductible in 47 states on formulary drugs in all five drug tiers. Drug tiers indicate the level of cost-sharing for a covered drug, for example, beneficiaries typically pay lower copays for drugs in lower tiers. In addition, beneficiaries will have $0 copays for 90-day supplies of Tier 1 drugs when using CVS Caremark Mail Service Pharmacy and lower premiums than 2017 in 48 states.

"For 2018 we have worked to reduce premiums for the majority of SilverScript plans across the country and to provide beneficiaries in our plans with continued access to a $0-deductible for drugs on all tiers," said Todd Meek, president, SilverScript Insurance Company, CVS Health.

SilverScript Choice and SilverScript Plus

SilverScript Choice is a basic plan that offers comprehensive coverage with competitive premiums, $0 deductible on all covered drugs in 47 states, and $0copays for 90-day supplies of Tier one drugs nationwide when filled through the CVS Caremark Mail Service Pharmacy. New to the SilverScript Choice Plan this year, beneficiaries managing diabetes can take advantage of significant savings on long-acting insulin drugs. In fact, for 2018, three injectable insulin medications will be covered in Tier 2; down tiered from Tier 3 in 2017. This may represent a potential savings of up to 60-75 percent (compared to 2017 copays for 30-day supplies) for each prescription filled for these drugs during Medicare's Initial Coverage Stage.

SilverScript Plus is an enhanced plan that provides additional coverage in the Coverage Gap (or Donut Hole). The Plus plan is designed for people who take several medications on a regular basis and are likely to reach the Coverage Gap during the 2018 plan year. SilverScript Plus offers lower monthly premiums than in 2017, $0 deductible on all covered drugs, and $0 copays for 90-day supplies of both Tier 1 and Tier 2 drugs nationwide through the CVS Caremark Mail Service Pharmacy. SilverScript Plus beneficiaries can also save on their drug costs by using a preferred pharmacy in a network that includes more than 37,000 retail pharmacies, including national leading chains, plus thousands of regional and local independent pharmacies across the country.

SilverScript Awarded 4-star High Performer Rating Issued by CMS

SilverScript maintained its 4-star performance rating from CMS for 2018, surpassing industry standards in delivering value, clinical outcomes and customer service. CMS annually evaluates and rates plan performance of Medicare Part D prescription drug plans based on quality, value and service measures. Plans are scored on a scale of one to five, with five stars being the highest achievable rating.

"We are proud to achieve a 4-Star rating from CMS, and we are focused on continued improvement as we strive to maintain our performance and quality rating," added Mitch Betses, executive vice president, member services, CVS Health. "As an objective tool, the CMS Star Ratings system is a helpful way for Medicare eligible individuals, who are making annual coverage elections, to easily identify which prescription drug plans will offer high quality service and value and be assured of industry-leading coverage."

Enrollment during the Medicare Annual Enrollment Period for the 2018 plan year runs from October 15, 2017 through December 7, 2017. Consumers interested in learning more about the SilverScript plan options can visit www.silverscript.com, or call toll-free 1-866-552-6106, 24 hours a day, 7 days a week. TTY users call 1-866-552-6288.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

 

Media Contacts:

Christine Cramer
CVS Health
401-770-3317
christine.cramer@cvshealth.com 

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

Roll Call Live: Empowering Patients as Partners in Health Care

Roll Call Live: Empowering Patients as Partners in Health Care
Bottom of the article

With the expansion of high-deductible health plans (HDHPs), patients are taking on more responsibility in deciding what options work best for their budgets and health care needs. Roll Call Live’s “Empowering Patients as Partners in Health Care,” sponsored by CVS Health, explored consumer-driven health care – examining where progress is being made and where opportunities for improvement still exist.

The event included two keynote conversations by policymakers, an expert panel discussion and remarks by Tom Moriarty, CVS Health Chief Policy and External Affairs Officer and General Counsel, who highlighted solutions for improving prescription drug affordability.

Other participants included:

  • Joseph Antos, PhD, Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute

  • Brian Blase, National Economic Council’s Special Assistant to the President for Economic Policy

  • David Blumenthal, MD, MPP, President of The Commonwealth Fund

  • Representative Donald McEachin (D-VA)

Participants highlighted three potential solutions to help empower patients as consumers: enhancing meaningful price transparency information; providing greater benefit flexibility for HDHPs associated with health savings accounts (HSAs); and expanding personalized care. 

Providing Meaningful, Transparent Information to Empower Decision-Making

As steps are being taken to increase transparency, experts believe it is important to make sure that information about health care benefits and costs is actionable for consumers. For example, Rep. Donald McEachin emphasized that transparent cost information alone isn’t enough – it must direct patients to effective care at a lower cost.

As David Blumenthal pointed out, “price information is as complicated as the health needs of the individual consuming the care,” and therefore, information should be presented clearly and be specific to a patients’ benefit plan. Supporting this, Joseph Antos explained that for information to be useful, it needs to be tailored to what patients care about – “for example, what they will actually be paying for at the pharmacy counter.”

Finding opportunities to increase transparency that improve health care decision-making is a top priority at CVS Health. Our solutions, including the Rx Savings Finder and real-time benefits, provide greater transparency from the point of prescribing to the point of sale with actionable results that are saving patients money.

Making HDHPs Work Better for More Patients

As the number of patients enrolled in HDHPs continues to grow, there are opportunities to improve how these plans work for patients, particularly those managing a chronic disease. Brian Blase outlined how the Administration is considering a proposal that would permit HDHPs associated with HSAs to cover more services, such as providing insulin at no cost to patients. Blase referred to this concept as “one possible way to help use insurance design to drive value by empowering patients as consumers of health care.” 

At CVS Health, we advocate changing the rules governing HSAs to give HDHPs the option to cover all prescription drugs — including generic and brand drugs — outside the deductible. That way, patients can access these drugs for little or no copay if that is how the plans want to structure their benefit. CVS Health also works with PBM clients to offer preventive drug lists for many common chronic diseases, including diabetes and heart disease, making it easier to access and afford care that puts people on a path to better health.

Connecting Patients to High-Value, Personalized Care

Incentivizing personalized care delivery that meets patients’ specific health needs can reduce costly complications and improve outcomes. The experts agreed that in the era of consumer-driven health care, more can be done to connect patients to the right care at the right time. David Blumenthal noted, “Insulin for diabetics is high-value care…hypertensive treatment, hypolipidemics for elevated lipids, exercise programs for people who are post-heart attack. These things are proven life-savers, and they shouldn’t be treated the same way as an unnecessary MRI for back pain.”

Whether it’s delivering preventive services that help keep people healthy or supporting chronic disease patients in adhering to their medications, we help connect patients to high-value care when and where they need it.  

For more information on how CVS Health is working to expand access to more affordable and effective health care, check out our Cost of Care information center and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our bi-weekly health care newsletter.

The stage at the Roll Call event
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off